Fig. 2: Event-free survival over 18 months of follow-up in 1703 patients with ACS. | The Pharmacogenomics Journal

Fig. 2: Event-free survival over 18 months of follow-up in 1703 patients with ACS.

From: New genetic variants associated with major adverse cardiovascular events in patients with acute coronary syndromes and treated with clopidogrel and aspirin

Fig. 2: Event-free survival over 18 months of follow-up in 1703 patients with ACS.

Cumulative probabilities of survival without MACE according to gene polymorphisms: MYOM2 (rs17064642), WDR24 (rs11640115), NECAB1 (rs74569896), EFR3A (rs4736529), AGAP3 (rs75750968), ZDHHC3 (rs3749187), ECHS1 (rs140410716), and KRTAP10-4 (rs201441480). The red, green, and blue colors represented the genotypes containing two, one or zero copy of the risk allele, respectively.

Back to article page